| LncRNA DLEU1 promotes angiogenesis in diabetic foot ulcer wound healing by regulating miR-96-5p. | LncRNA DLEU1 promotes angiogenesis in diabetic foot ulcer wound healing by regulating miR-96-5p.
Yang M, Gu Y. | 01/30/2024 |
| [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma]. | [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
Zhang JJ, Yang P, Shang XQ. | 07/5/2023 |
| Overexpression of lncRNA DLEU1 in Gastric Cancer Tissues Compared to Adjacent Non-Tumor Tissues. | Overexpression of lncRNA DLEU1 in Gastric Cancer Tissues Compared to Adjacent Non-Tumor Tissues.
Ghodrati R, Safaralizadeh R, Dastmalchi N, Hosseinpourfeizi M, Asadi M, Shirmohammadi M, Baradaran B. | 11/12/2022 |
| LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis. | LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis.
Sun KD, Ni YJ, Qin H, Xu QF. | 10/15/2022 |
| YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. | YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.
Li J, Jiang X, Xu Y, Kang P, Huang P, Meng N, Wang H, Zheng W, Wang H, Wang Z, Zhong X, Cui Y., Free PMC Article | 07/30/2022 |
| Long non-coding RNA DLEU1 promotes malignancy of breast cancer by acting as an indispensable coactivator for HIF-1alpha-induced transcription of CKAP2. | Long non-coding RNA DLEU1 promotes malignancy of breast cancer by acting as an indispensable coactivator for HIF-1α-induced transcription of CKAP2.
Ma HN, Chen HJ, Liu JQ, Li WT., Free PMC Article | 07/30/2022 |
| lncRNA DLEU1 Modulates Proliferation, Inflammation, and Extracellular Matrix Degradation of Chondrocytes through Regulating miR-671-5p. | lncRNA DLEU1 Modulates Proliferation, Inflammation, and Extracellular Matrix Degradation of Chondrocytes through Regulating miR-671-5p.
Wu X, Yin S, Yan L, Liu Y, Shang L, Liu J., Free PMC Article | 06/11/2022 |
| DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma. | DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma.
Li Q, Zhang Z, Jiang H, Hou J, Chai Y, Nan H, Li F, Wang L., Free PMC Article | 06/11/2022 |
| Survivalrelated DLEU1 is associated with HPV infection status and serves as a biomarker in HPVinfected cervical cancer. | Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.
Dong A, Xu B, Wang Z, Miao X., Free PMC Article | 04/2/2022 |
| LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis. | LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis.
Zheng C, Liu S, Qin Z, Zhang X, Song Y., Free PMC Article | 02/19/2022 |
| DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes. | DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes.
Hatanaka Y, Niinuma T, Kitajima H, Nishiyama K, Maruyama R, Ishiguro K, Toyota M, Yamamoto E, Kai M, Yorozu A, Sekiguchi S, Ogi K, Dehari H, Idogawa M, Sasaki Y, Tokino T, Miyazaki A, Suzuki H., Free PMC Article | 01/29/2022 |
| Knockdown of lncRNA DLEU1 inhibits the tumorigenesis of oral squamous cell carcinoma via regulation of miR1495p/CDK6 axis. | Knockdown of lncRNA DLEU1 inhibits the tumorigenesis of oral squamous cell carcinoma via regulation of miR‑149‑5p/CDK6 axis.
Lv T, Liu H, Wu Y, Huang W., Free PMC Article | 10/23/2021 |
| Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis. | Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H, Wang L, Jiang X. | 07/17/2021 |
| [Deleted in lymphocytic leukemia 1 promoted proliferation and apoptosis of nephroblastoma cells through regulating miR-513a-5p and RANBP2 pathway]. | [Deleted in lymphocytic leukemia 1 promoted proliferation and apoptosis of nephroblastoma cells through regulating miR-513a-5p and RANBP2 pathway].
Zhao JL, Zhao LL, Niu WZ, Ding XC, Zhang WL. | 01/9/2021 |
| SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma. | SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma.
Liu X, Chen R, Liu L., Free PMC Article | 10/24/2020 |
| LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells. | LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C, Xie XX, Li WJ, Jiang DQ. | 10/24/2020 |
| Up regulation of DLEU1 expression by epigenetic modification promotes tumorigenesis in human cancer | Upregulation of DLEU1 expression by epigenetic modification promotes tumorigenesis in human cancer.
Pang B, Sui S, Wang Q, Wu J, Yin Y, Xu S. | 06/6/2020 |
| Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 | Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis.
Gao S, Cai Y, Zhang H, Hu F, Hou L, Xu Q. | 04/11/2020 |
| these results indicated a prooncogenic role of DLEU1 in the progression and development of renal cell carcinoma via modulation of the Akt pathway and EMT phenotype. | Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway.
Yue G, Chen C, Bai L, Wang G, Huang Y, Wang Y, Cui H, Xiao Y., Free PMC Article | 04/4/2020 |
| Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis | Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis.
Chen X, Zhang C, Wang X. | 01/4/2020 |
| Small interfering RNA demonstrated that silencing DLEU1 downregulated TRAF4. The viability of Glioblastoma multiforme (GBM)cells was significantly decreased following RNA interference with DLEU1 and TRAF4 production. | Long non‑coding RNA DLEU1 promotes cell proliferation of glioblastoma multiforme.
Wang J, Quan X, Peng D, Hu G. | 12/28/2019 |
| lncRNA DLEU1 combines with mTOR and then increases the expression of PI3K/AKT/mTOR pathway to promote endometrial carcinoma tumorigenesis and progression. Silence of mTOR after up-regulation of lncRNA DLEU1 resulted in decrease of cell viability, migration, and invasion and increase of apoptosis. | lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.
Du Y, Wang L, Chen S, Liu Y, Zhao Y. | 04/27/2019 |
| DLEU1 promoted tumorigenesis and progression of non-small cell lung cancer. | Long non-coding RNA DLEU1 exerts an oncogenic function in non-small cell lung cancer.
Zhang S, Guan Y, Liu X, Ju M, Zhang Q. | 04/6/2019 |
| Data found that DLEU1 was up-regulated in CRC tissues. Its overexpression promoted CRC cell proliferation, migration and invasion. DLEU1 co-localized with SMARCA1 in CRC, and is indispensable for the deposition of SMARCA1 at the promoter of KPNA3 gene. Collectively, DLEU1 recruited SMARCA1 to epigenetically activate KPNA3, thereby promoting proliferation and migration in colorectal cancer. | LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3.
Liu T, Han Z, Li H, Zhu Y, Sun Z, Zhu A., Free PMC Article | 03/23/2019 |
| Our findings indicate that DLEU1 contributes to endometrial cancer development by sponging miR-490 to regulate SP1 expression | Long non-coding RNA DLEU1 contributes to the development of endometrial cancer by sponging miR-490 to regulate SP1 expression.
Shao W, Li Y, Chen F, Jia H, Jia J, Fu Y. | 12/22/2018 |